CARsgen Therapeutics Holdings Limited (HKG:2171)
12.84
-0.59 (-4.39%)
Sep 10, 2026, 1:15 PM HKT
HKG:2171 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, HKG:2171 stock has a consensus rating of "Hold" and an average price target of $18.39. The average 1-year stock price forecast is 43.22% higher than the current stock price, while the lowest is $13.88 (+8.10%) and the highest is $22.89 (+78.27%).
Price Target: $18.39 (+43.22%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for HKG:2171 stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 2 | 2 | 2 | 2 | 2 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Sell Maintains $16.09 → $13.82 | Sell | Maintains | $16.09 → $13.82 | +7.63% | Aug 20, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $25.70 | Buy | Maintains | $25.70 | +100.16% | Jun 22, 2026 |
Financial Forecast
Revenue This Year
296.23M
from 125.66M
Increased by 135.73%
Revenue Next Year
658.99M
from 296.23M
Increased by 122.46%
EPS This Year
-0.47
from -0.13
EPS Next Year
1.22
from -0.47
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.